| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 6, Issue 6 691-698, Copyright © 1995 by American Association of Cancer Research
ARTICLES |
K Rhee, D Reisman, W Bresnahan and EA Thompson
Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston 77550, USA.
These experiments were undertaken to study cell cycle-dependent regulation of expression of genes encoding cyclin-dependent kinases (Cdks). P1798 T-lymphoma cells were studied as a model system, since these cells undergo reversible G0 arrest within 24 h after addition of 0.1 microM dexamethasone to mid log phase cultures. G0 arrest is associated with inhibition of expression of several Cdks. The mRNAs encoding Cdk1 and Cdk4 decreased by 80-90% within 24 h. Fifty % inhibition of Cdk4 mRNA occurred within about 4 h, and 50% inhibition of Cdk1 mRNA was observed within 12-14 h. There was a slight decrease (< 50%) in the abundance of the mRNAs encoding Cdk2 and Cdk5. Cdk6 mRNA did not decrease in glucocorticoid-treated cells. Cdk1 and Cdk2 protein levels were reduced by no more than 50-70% within 24 h after the addition of dexamethasone, and the amounts of Cdk5 and Cdk6 protein did not change. However, the amount of Cdk4 protein decreased by > 90% under these circumstances. P1798 cells enter S phase in a synchronous fashion within 16-20 h after removal of dexamethasone. Cdk1, Cdk2, and Cdk5 mRNAs and proteins increased at or after the time that cells began to enter S phase. The mRNA encoding Cdk4 increased much more rapidly after removal of glucocorticoids, and a 5-fold increase in Cdk4 mRNA abundance was observed within 8 h after removal of the steroid. A corresponding increase in Cdk4 protein was observed, indicating that inhibition of Cdk4 expression is more proximal to the glucocorticoid-induced blockade in G1 progression.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
L.-G. Bladh, J. Liden, A. Pazirandeh, I. Rafter, K. Dahlman-Wright, S. Nilsson, and S. Okret Identification of Target Genes Involved in the Antiproliferative Effect of Glucocorticoids Reveals a Role for Nuclear Factor-{kappa}B Repression Mol. Endocrinol., March 1, 2005; 19(3): 632 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, C. Finnerty, W. C. Gustafson, C. R. Bush, P. Chi, H. Guo, B. Luxon, A. P. Fields, and E. A. Thompson Genomic Analysis of Glucocorticoid-regulated Promoters in Murine T-lymphoma Cells Recent Prog. Horm. Res., January 1, 2003; 58(1): 155 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Fingerle-Rowson, P. Koch, R. Bikoff, X. Lin, C. N. Metz, F. S. Dhabhar, A. Meinhardt, and R. Bucala Regulation of Macrophage Migration Inhibitory Factor Expression by Glucocorticoids in Vivo Am. J. Pathol., January 1, 2003; 162(1): 47 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Greenberg, J. Hu, S. Basu, J. Hay, J. Reibman, T.-a. Yie, K. M. Tchou-Wong, W. N. Rom, and T. C. Lee Glucocorticoids Inhibit Lung Cancer Cell Growth through Both the Extracellular Signal-Related Kinase Pathway and Cell Cycle Regulators Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 320 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. CROCHEMORE, T. M. MICHAELIDIS, D. FISCHER, J.-P. LOEFFLER, and O. F. X. ALMEIDA Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation FASEB J, June 1, 2002; 16(8): 761 - 770. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fernandes, E. Guida, V. Koutsoubos, T. Harris, P. Vadiveloo, J. W. Wilson, and A. G. Stewart Glucocorticoids Inhibit Proliferation, Cyclin D1 Expression, and Retinoblastoma Protein Phosphorylation, but Not Activity of the Extracellular-Regulated Kinases in Human Cultured Airway Smooth Muscle Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 77 - 88. [Abstract] [Full Text] |
||||
![]() |
N. Baghdassarian, A. Peiretti, E. Devaux, P. André Bryon, and M. Ffrench Involvement of p27Kip1 in the G1- and S/G2-phase Lengthening Mediated by Glucocorticoids in Normal Human Lymphocytes Cell Growth Differ., June 1, 1999; 10(6): 405 - 412. [Abstract] [Full Text] |
||||
![]() |
L.-P. Wen, K. Madani, J. A. Fahrni, S. R. Duncan, and G. D. Rosen Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-gamma and Fas Am J Physiol Lung Cell Mol Physiol, November 1, 1997; 273(5): L921 - L929. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ramalingam, A. Hirai, and E. A. Thompson Glucocorticoid Inhibition of Fibroblast Proliferation and Regulation of the Cyclin Kinase Inhibitor p21Cip1 Mol. Endocrinol., May 1, 1997; 11(5): 577 - 586. [Abstract] [Full Text] |
||||
![]() |
E. Smith, R. A. Redman, C. R. Logg, G. A. Coetzee, N. Kasahara, and B. Frenkel Glucocorticoids Inhibit Developmental Stage-specific Osteoblast Cell Cycle. DISSOCIATION OF CYCLIN A-CYCLIN-DEPENDENT KINASE 2 FROM E2F4-p130 COMPLEXES J. Biol. Chem., June 23, 2000; 275(26): 19992 - 20001. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |